← Holders
Aisling Capital Management LP
What Aisling Capital Management LP reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 1766721 · Filed Nov 12, 2026
- Positions
- 14
- Reported value
- $299.3M
- Opened
- 0
- Closed
- 0
- Other managers included
- 0
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
Quarters on file
- Sep 30, 2025$456.4M14 positions
- Dec 31, 2025$478.9M13 positions
- Mar 31, 2026$476.3M13 positions
- Jun 30, 2026$471.6M14 positions
- Sep 30, 2026$299.3M14 positions
| Security | Shares | Change | Value | Of portfolio |
|---|---|---|---|---|
BBIOBridgeBio Pharma, Inc. | 3.1M | −32.7% | $203.3M | 67.9% |
SNDXSyndax Pharmaceuticals Inc | 1.3M | ±0% | $24.8M | 8.3% |
CMPSCOMPASS Pathways plc | 1.7M | +20.9% | $21.6M | 7.2% |
GLUEMonte Rosa Therapeutics, Inc. | 1.6M | ±0% | $18.6M | 6.2% |
BCAXBicara Therapeutics Inc. | 548.9K | −3.5% | $10.2M | 3.4% |
URGNUroGen Pharma Ltd. | 108K | ±0% | $4.4M | 1.5% |
BBOTBridgeBio Oncology Therapeutics, Inc. | 1M | ±0% | $4.1M | 1.4% |
EPRXEupraxia Pharmaceuticals Inc. | 325K | ±0% | $3M | 1% |
BMEABiomea Fusion, Inc. | 2M | ±0% | $2.7M | 0.9% |
ACRSAclaris Therapeutics, Inc. | 434.5K | ±0% | $2.3M | 0.8% |
SRRKScholar Rock Holding Corp | 42K | −45.4% | $2M | 0.7% |
VTVTvTv Therapeutics Inc. | 58.8K | +17.5% | $1.8M | 0.6% |
MRKRMarker Therapeutics, Inc. | 325.4K | ±0% | $348.1K | 0.1% |
OKUROnKure Therapeutics, Inc. | 88.6K | ±0% | $241.5K | 0.1% |